Page last updated: 2024-08-25

4-aminopyrazolo(3,4-d)pyrimidine and Obesity

4-aminopyrazolo(3,4-d)pyrimidine has been researched along with Obesity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dey, AB; Estridge, TB; Fretland, AJ; Hartley, M; Jin, N; Kowala, MC; Leohr, JK; Luffer-Atlas, D; Luo, MJ; Mabry, TE; Milligan, PL; Reidy, C; Yu, X; Zhang, Y1

Other Studies

1 other study(ies) available for 4-aminopyrazolo(3,4-d)pyrimidine and Obesity

ArticleYear
Identification of 4-Aminopyrazolopyrimidine Metabolite That May Contribute to the Hypolipidemic Effects of LY2584702 in Long Evans Diet-Induced Obese Rats.
    The Journal of pharmacology and experimental therapeutics, 2017, Volume: 362, Issue:1

    Topics: Adenine; Animals; Cholesterol, LDL; Cholesterol, VLDL; Gene Expression Regulation; Hep G2 Cells; Humans; Hypolipidemic Agents; Lipid Metabolism; Lipoproteins, LDL; Liver; Male; Obesity; Pyrazoles; Pyrimidines; Rats; Rats, Long-Evans; Triglycerides

2017